fertigest 0.004 mg/ml solution for injection
vetpharma animal health, s.l. - buserelin acetate - solution for injection - 0.004 milligram(s)/millilitre - buserelin - cattle, horses, pigs, rabbits - hormone
suprefact 100 mcg/dose nasal spray solution
sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues
suprefact
sanofi-aventis new zealand limited - buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin - solution for injection - 1 mg/ml - active: buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin excipient: benzyl alcohol monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - for the treatment of endometriosis not primarily requiring surgical treatment. pituitary desensitisation in preparation for ovulation induction regimens using gonadotrophins.
suprefact 5.5mg/5.5ml solution for injection vials
neon healthcare ltd - buserelin acetate - solution for injection - 1mg/1ml
suprecur 5.5mg/5.5ml solution for injection vials
neon healthcare ltd - buserelin acetate - solution for injection - 1mg/1ml
suprecur 150micrograms/dose nasal spray
neon healthcare ltd - buserelin acetate - spray - 150microgram/1dose
suprefact 100micrograms/dose nasal spray
neon healthcare ltd - buserelin acetate - spray - 100microgram/1dose
suprelorin 9.4 mg
virbac (australia) pty ltd - deslorelin as deslorelin acetate - parenteral implant, device - deslorelin as deslorelin acetate ungrouped active 9.4 mg/im - endocrine system - dog - male - reducing testosterone production
suprelorin 4.7 mg
virbac (australia) pty ltd - deslorelin as deslorelin acetate - parenteral implant, device - deslorelin as deslorelin acetate ungrouped active 4.7 mg/im - endocrine system - dog - male - reducing testosterone production
cetrotide
pharmacy retailing (nz) ltd t/a healthcare logistics - cetrorelix acetate 0.26mg equivalent to 0.25 mg cetrorelix - injection with diluent - 250 mcg - active: cetrorelix acetate 0.26mg equivalent to 0.25 mg cetrorelix excipient: mannitol water for injection - prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.